Jon,

Thank you for always keeping me informed...Your
efforts are appreciated!

Eric

--- Jon <jmonkey74@...> wrote:

> AIDSmeds.com newsletter
> <http://www.aidsmeds.com/>
> *News From AIDSmeds.com and Reuters Health*
>
>
> February 07, 2007
>
> GSK Offers Rebate Card to Lexiva Users
> <http://www.aidsmeds.com/articles/1667_11235.shtml>
> (AIDSmeds.com) GlaxoSmithKline announced this week
> that it has
> introduced a rebate program for its protease
> inhibitor Lexiva
> (fosamprenavir). The new Patient Support Cards will
> provide some
> HIV-positive patients with a credit of up to $50
> toward their
> out-of-pocket expenses for Lexiva, every time their
> prescription for
> the drug is filled for a total of two years.
>
>
> February 02, 2007
>
> Hep C: Heavy Drinking Riskier for Women than Men
> <http://www.aidsmeds.com/articles/1667_11217.shtml>
> (Reuters Health) Heavy alcohol use increases
> mortality with
> hepatitis C to a greater extent in female patients
> than in males,
> according to a report in the February issue of
> Alcoholism: Clinical
> and Experimental Research.
>
> HIV Rates Drop Among Florida Blacks
> <http://www.aidsmeds.com/articles/1667_11218.shtml>
> (Reuters Health) Between 1999 and 2004, the rates of
> new HIV/AIDS
> diagnoses declined among blacks living in Florida,
> according to a
> report by investigators at the Florida Department of
> Health and the
> Centers for Disease Control and Prevention. The
> annual rate of
> decline was significantly greater than for other
> racial/ethnic
> groups.
>
>
> February 01, 2007
>
> Asthma Med for IRIS?
> <http://www.aidsmeds.com/articles/1667_11207.shtml>
> (AIDSmeds.com) Doctors in London have reported
> encouraging results
> using a common asthma medication to treat an
> HIV-positive man with
> immune reconstitution inflammatory syndrome (IRIS).
> The case report,
> published in the January 30 issue of AIDS, suggests
> that the
> patient's rapid recovery upon starting treatment
> with the
> leukotriene inhibitor montelukast (Singulair) may
> also provide
> important information about the mechanisms
> responsible for IRIS seen
> in many HIV-positive people receiving antiretroviral
> therapy.
>
> Despite Setback, Advocates Push for Continued
> Microbicide Research
> <http://www.aidsmeds.com/articles/1667_11208.shtml>
> (AIDSmeds.com) HIV prevention advocates are
> emphasizing the
> importance of continued research into new HIV
> prevention options,
> despite the recent discontinuation of the Phase III
> effectiveness
> trials of the microbicide candidate, cellulose
> sulfate (CS).
>
>
> January 31, 2007
>
> After the Hype, Depakote no Cure for HIV
> <http://www.aidsmeds.com/articles/1667_11202.shtml>
> (AIDSmeds.com) Long-awaited data from a follow-up
> study of valproic
> acid (Depakote) indicate that it is not likely to be
> a cure for HIV
> infection. The new report, published on the Journal
> of Infectious
> Diseases website ahead of its official printing,
> debunks a paper
> released two years ago suggesting that the widely
> available
> anti-seizure medication may help decrease the pool
> of latent HIV in
> the body and, in turn, potentially allow for the
> eradication of the virus.
>
>
>
> Copyright 2007 Smart + Strong, 500 Fifth Avenue,
> Suite 320, New York,
> NY 10110. All rights reserved.
>
>
>
>




________________________________________________________________________________\
____
8:00? 8:25? 8:40? Find a flick in no time
with the Yahoo! Search movie showtime shortcut.
http://tools.search.yahoo.com/shortcuts/#news